Bubs Australia Limited ACN 060 094 742 23-29 Nina Link, Dandenong South VIC 3175 Australia 1800 2827 2878 (1800 BUBS AUST) info@bubsaustralia.com ASX ANNOUNCEMENT 2026 ANNUAL GENERAL MEETING – CHAIR AND CEO ADDRESS 18 November 2026, Melbourne: Bubs Australia Limited (ASX:BUB) (“Bubs” or...
AGM CEO and Chair Address
Filed with ASX · · 12 pages · English
Summary by 6ix AI
Bubs Australia Ltd. has released the Chair and CEO Address for its Annual General Meeting, detailing the company's progress and strategic objectives for the year. The address highlights significant achievements, including securing permanent FDA authorization for key products in the United States, which is now the company's principal growth market. Despite revenue growth, the company faced challenges such as increased costs and a reported loss, prompting a focus on improving financial performance and shareholder value. The leadership emphasizes the importance of governance, product quality, and strategic execution as they move forward into the next fiscal year.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from Bubs Australia
- Withdrawal of Resolution
- Change of Director's Interest Notice - PJ
- Change of Director's Interest Notice - PDP
- Quarterly Activities/Appendix 4C Cash Flow Report
- Response to ASX 3Y Query
Later from Bubs Australia
All Bubs Australia news releasesFollow Bubs Australia into a list and get an email when it puts out news.
Follow Bubs Australia